Cargando…

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)

Vaccines against SARS-CoV-2 are believed to play a key role in the suppression of the COVID-19 pandemic. However, patients suffering from inflammatory bowel diseases (IBD) were excluded from SARS-CoV-2 vaccines trials. Therefore, concerns regarding vaccination efficacy and safety among those patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubas, Aleksandra, Malecka-Wojciesko, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104993/ https://www.ncbi.nlm.nih.gov/pubmed/35566802 http://dx.doi.org/10.3390/jcm11092676

Ejemplares similares

Dietary Interventions in Inflammatory Bowel Disease
por: Godala, Małgorzata, et al.
Publicado: (2022)

Protease-Activated Receptors – Key Regulators of Inflammatory Bowel Diseases Progression
por: Jacenik, Damian, et al.
Publicado: (2021)

Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment
por: Dudek, Patrycja, et al.
Publicado: (2021)

Dietary Behaviors and Beliefs in Patients with Inflammatory Bowel Disease
por: Godala, Małgorzata, et al.
Publicado: (2023)

Evaluation of Albumin, Transferrin and Transthyretin in Inflammatory Bowel Disease Patients as Disease Activity and Nutritional Status Biomarkers
por: Godala, Małgorzata, et al.
Publicado: (2023)

Role of Serum Interleukin-6, Interleukin-1β and Interleukin-10 in Assessment of Disease Activity and Nutritional Status in Patients with Inflammatory Bowel Disease
por: Godala, Małgorzata, et al.
Publicado: (2023)

Clinical and Laboratory Characteristics of Anaemia in Hospitalized Patients with Inflammatory Bowel Disease
por: Woźniak, Małgorzata, et al.
Publicado: (2023)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
por: Sochal, Marcin, et al.
Publicado: (2021)

The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review
por: Daniluk, Jaroslaw, et al.
Publicado: (2022)

Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease
por: Woźniak, Małgorzata, et al.
Publicado: (2023)

The Effect of Serotonin Transmission on Depressive and Insomnia Symptoms in Inflammatory Bowel Diseases
por: Sochal, Marcin, et al.
Publicado: (2023)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

The 2023 Impact of Inflammatory Bowel Disease in Canada: COVID-19 and IBD
por: Kaplan, Gilaad G, et al.
Publicado: (2023)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

The incidence of adult type hypolactasia in patients with irritable bowel syndrome
por: Domżał-Magrowska, Danuta, et al.
Publicado: (2023)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023)

Sleep Problems in Chronic Inflammatory Diseases: Prevalence, Treatment, and New Perspectives: A Narrative Review
por: Ditmer, Marta, et al.
Publicado: (2021)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Pancreatic Incidentaloma
por: Caban, Miłosz, et al.
Publicado: (2022)

Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?
por: Kapszewicz, Monika, et al.
Publicado: (2021)

Diagnosis and Management of Barrett’s Esophagus
por: Mejza, Maja, et al.
Publicado: (2023)

Eosinophilic Esophagitis—What Do We Know So Far?
por: Wąsik, Jakub, et al.
Publicado: (2023)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
por: Michalak, Natalia, et al.
Publicado: (2023)

Leukocytapheresis in patients with inflammatory bowel diseases
por: Woźniak, Małgorzata, et al.
Publicado: (2021)

Association between brain-derived neurotrophic factor and symptoms of insomnia and depression in inflammatory bowel disease (IBD) patients
por: Sochal, M., et al.
Publicado: (2021)

Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study”
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Bioelectronics in the brain–gut axis: focus on inflammatory bowel disease (IBD)
por: Stakenborg, Nathalie, et al.
Publicado: (2021)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

Controlled drug release for inflammatory bowel disease (IBD)
por: Asha, D, et al.
Publicado: (2020)

Recipe for IBD: can we use food to control inflammatory bowel disease?
por: Witkowski, Mario, et al.
Publicado: (2017)

The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)—A Critical Review
por: Jakubczyk, Dominika, et al.
Publicado: (2020)

Metabolic Host–Microbiota Interactions in Autophagy and the Pathogenesis of Inflammatory Bowel Disease (IBD)
por: Dowdell, Alexander S., et al.
Publicado: (2021)

Nutritional Assessment in Inflammatory Bowel Disease (IBD)—Development of the Groningen IBD Nutritional Questionnaires (GINQ)
por: Peters, Vera, et al.
Publicado: (2019)

Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients
por: Zhang, Long-Juan, et al.
Publicado: (2019)

Impact of the coronavirus infectious disease (COVID-19) pandemic on the provision of inflammatory bowel disease (IBD) antenatal care and outcomes of pregnancies in women with IBD
por: Selinger, Christian Philipp, et al.
Publicado: (2021)

Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease
por: Sochal, Marcin, et al.
Publicado: (2023)

AF.49 DETERMINANTS OF COVID-19 VACCINE HESITANCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): RESULTS OF A NATIONAL SURVEY OF THE ITALIAN IBD PATIENTS’ ASSOCIATION (AMICI ONLUS)
por: Costantino, A., et al.
Publicado: (2021)

Thromboembolic tendency (TE) in IBD (inflammatory bowel disease) patients
por: Canero, A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_t158q8dhgkqfm68768dbkpjh8s